7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      cash flows from operating activities:
    		                   
      net income
    		                   
      adjustments to reconcile net income to net cash from operating activities
    		                   
      impairment loss
    		0 404,855,000 3,631,000 0        141,000,000 0       
      depreciation and amortization expense
    		4,642,000 6,631,000 9,585,000 18,074,000 18,312,000 17,024,000 17,206,000             
      changes in fair value of interest rate swaps
    		638,000 1,234,000 2,636,000  8,687,000 -114,000 -1,578,000  3,796,000 1,000,000 4,233,000  -4,774,000 -2,813,000 -10,817,000  -46,000 201,000 -2,944,000 
      changes in fair value of contingent earn-out liability
    		-1,596,000 1,701,000 -2,282,000 1,824,000 -2,689,000 -3,654,000 -15,689,000 -5,328,000 -11,308,000 -12,287,000 -646,000  -27,004,000 1,314,000 -20,709,000     
      non-cash lease expense
    		806,000 834,000 790,000 804,000 815,000 889,000 894,000 878,000 893,000 885,000 862,000 1,060,000 1,106,000 1,204,000 1,169,000 1,191,000    
      tax receivable agreement liability remeasurement expense
    		-186,000 29,000 857,000 7,390,000 721,000 0 230,000             
      deferred income tax
    		948,000 557,000 1,327,000 4,708,000 -1,172,000 1,322,000 164,000 1,714,000 -3,364,000 -2,795,000 -2,721,000 1,047,000 -3,226,000 -314,000 -2,961,000 -4,818,000 30,000 -159,000 -441,682,000 
      stock-based compensation expense
    		11,610,000 5,849,000 4,138,000 13,972,000 10,158,000 2,089,000 26,000 20,678,000 21,528,000 33,548,000 28,584,000 33,829,000 37,175,000 22,447,000 17,557,000 24,408,000 23,763,000 29,916,000 45,823,000 
      net foreign exchange difference
    		-12,767,000 14,775,000 10,860,000 -20,660,000 7,357,000 513,000 145,000 4,223,000 -2,973,000 1,663,000 -1,990,000 16,984,000 -8,878,000 170,000 -5,705,000 10,949,000 556,000 -5,114,000 -2,307,000 
      other
    		3,603,000 506,000 1,058,000 19,401,000 -13,196,000 778,000 -3,237,000 9,825,000 -22,053,000 11,146,000 12,147,000 -2,413,000 -1,829,000 -7,676,000 8,365,000 1,615,000 433,000 1,326,000 2,719,000 
      changes in assets and liabilities:
    		                   
      accounts receivable
    		7,703,000 -934,000 -720,000 4,526,000 -1,400,000 -904,000 3,566,000 -3,272,000 -1,778,000 -4,947,000 -26,034,000 -15,547,000 -1,433,000 -4,237,000 494,000 -4,999,000 20,784,000 -4,663,000 -21,075,000 
      other current assets
    		3,539,000 -1,682,000 1,559,000 -3,073,000 2,286,000 322,000 -4,267,000 -1,136,000 472,000 4,804,000 -7,060,000 2,703,000 -815,000 27,065,000 -5,989,000 29,612,000 155,000 1,795,000 -7,234,000 
      accounts payable
    		-5,084,000 4,150,000 -1,977,000 -326,000 1,098,000 -2,226,000 3,386,000 -689,000 -2,770,000 -803,000 6,037,000 -4,156,000 -684,000 1,198,000 -10,355,000 9,593,000 -4,508,000 578,000 -9,194,000 
      deferred revenue
    		-2,529,000 -242,000 -1,729,000 -1,918,000 -1,373,000 -74,000 -1,973,000 -556,000 1,195,000 933,000 1,021,000 1,210,000 782,000 3,791,000 106,000 881,000 1,713,000 3,959,000 2,101,000 
      legal liabilities
    		-25,000   -39,719,000 -816,000 -7,913,000 -17,315,000 43,765,000 19,725,000   19,125,000 -10,000 -6,370,000 -750,000 -746,000 -8,004,000 -7,384,000 -30,243,000 
      lease liabilities
    		-985,000 -1,023,000 -888,000 -185,000 -276,000 -366,000 -386,000 -939,000 -1,009,000 -1,023,000 -959,000         
      accrued expenses and other current liabilities
    		11,083,000 -3,172,000 -5,475,000 -15,359,000 21,345,000 -12,117,000 -12,880,000 -6,179,000 18,993,000 2,835,000 -14,164,000 3,097,000 -681,000 -35,488,000 -1,919,000 11,980,000 -16,120,000 -21,995,000 -4,410,000 
      net cash from operating activities
    		76,819,000 71,236,000 43,245,000 -5,398,000 93,494,000 32,925,000 2,420,000 63,417,000 62,569,000 42,711,000 13,389,000 51,172,000 37,002,000 25,409,000 19,358,000 91,384,000 44,892,000 14,143,000 -45,582,000 
      cash flows from investing activities:
    		                   
      capital expenditures
    		-3,025,000 -3,509,000 -2,411,000 -3,169,000 -1,619,000 -1,730,000 -2,801,000 -2,166,000 -3,559,000 -2,399,000 -6,811,000 -5,022,000 -3,262,000 -3,053,000 -4,996,000 -4,265,000 -3,836,000 -2,840,000 -2,712,000 
      free cash flows
    		73,794,000 67,727,000 40,834,000 -8,567,000 91,875,000 31,195,000 -381,000 61,251,000 59,010,000 40,312,000 6,578,000 46,150,000 33,740,000 22,356,000 14,362,000 87,119,000 41,056,000 11,303,000 -48,294,000 
      acquisition of intangible assets
    		   0                
      net cash from investing activities
    		-3,025,000 -3,509,000 -2,411,000 -3,169,000 -19,054,000 -1,730,000 -2,801,000 -2,166,000 -3,502,000 -12,276,000 -6,811,000 -5,022,000 -3,262,000 -3,053,000 -74,716,000 -3,127,000 -3,808,000 -2,806,000 -2,743,000 
      cash flows from financing activities:
    		                   
      repayment of term loan
    		-26,437,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 -1,437,000 -1,438,000 1,096,000 -1,438,000 -6,096,000 -200,000,000 
      distributions paid to noncontrolling interest holders
    		0 -5,187,000 -7,000 -41,000 -2,259,000 -2,897,000 -2,721,000 -23,000 -46,000           
      share repurchases
    		0 0 -28,682,000 -40,270,000 -89,735,000 0 -62,108,000 -91,940,000 0           
      purchase of common units
    		   0 -29,000 0 -22,155,000             
      withholding tax paid on behalf of employees on stock-based awards
    		-2,053,000 -2,314,000 -3,422,000 -1,142,000 -1,343,000 -2,303,000 -5,944,000 -2,827,000 -2,171,000 -2,373,000 -9,321,000  -1,158,000 -486,000 -5,708,000     
      payments on tax receivable agreement
    		0 0 -8,917,000 0                
      net cash from financing activities
    		-28,490,000 -8,938,000 -42,466,000 -43,079,000 -106,746,000 -6,637,000 -94,366,000 -140,536,000 -3,655,000 -38,532,000 -16,168,000 -3,289,000 -2,596,000 -1,923,000 -7,146,000 -8,242,000 -893,000 -6,096,000 166,717,000 
      effects of exchange rate changes on cash and cash equivalents
    		269,000 1,146,000 328,000 3,444,000 -2,660,000 -381,000 1,598,000 -4,163,000 2,419,000 -275,000 -4,261,000 -7,708,000 6,100,000 5,424,000 2,117,000 -2,415,000 -637,000 264,000 -162,000 
      net increase in cash and cash equivalents and restricted cash
    		   -48,202,000 -34,966,000 24,177,000 -93,149,000 -83,448,000 57,831,000 -8,372,000 -13,851,000    -60,387,000 77,600,000 39,554,000   
      cash and cash equivalents and restricted cash, beginning of the period
    		0 0 207,062,000 0 0 0 359,202,000 0 0 0 407,042,000    369,175,000 0 0   
      cash and cash equivalents and restricted cash, end of the period
    		45,573,000 59,935,000 205,758,000 -48,202,000 -34,966,000 24,177,000 266,053,000 -83,448,000 57,831,000 -8,372,000 393,191,000 35,153,000   308,788,000 77,600,000 39,554,000 5,762,000 246,259,000 
      less restricted cash
    		259,000 -127,000 -3,515,000 464,000 359,000 -212,000 -3,354,000 -94,000 334,000 436,000 -4,236,000 -11,267,000       257,000 
      cash and cash equivalents, end of the period
    		46,144,000 59,496,000 202,243,000 -47,738,000 -34,607,000 23,965,000 262,699,000 -83,542,000 58,165,000 -7,936,000 388,955,000 37,454,000 30,460,000 25,857,000 308,788,000 77,600,000 39,554,000 6,019,000 246,002,000 
      net earnings
    		 -366,983,000 19,831,000  -849,259,000 37,686,000 33,873,000 -32,012,000 23,124,000 9,349,000 -2,329,000 -159,246,000 27,607,000 -6,423,000 23,938,000 -14,679,000 -10,671,000 -11,147,000 323,442,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                   
      net increase in cash and cash equivalents and restricted cash, including cash classified within current assets held for sale
    		                   
      less cash classified within current assets held for sale
    		                   
      net decrease in cash and cash equivalents and restricted cash
    		  -1,304,000                 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      gain on settlement of lease liabilities
    		                   
      changes in fair value of interest rate swap
    		                   
      acquisition of business, net of cash acquired
    		       0 57,000   0 0 0 -69,720,000     
      debt issuance costs
    		                   
      loss on extinguishment of long term debt
    		                   
      proceeds from issuance of class a common stock sold in initial public offering, net of offering costs
    		               0 0 0 2,358,371,000 
      payments to purchase and retire common stock
    		               0 0   
      purchase of common units from pre-ipo common unitholders in the initial public offering
    		               0 0 0 -973,289,000 
      proceeds from exercise of options
    		               0    
      depreciation and amortization
    		        17,127,000 16,967,000 16,731,000 15,878,000 19,755,000 27,151,000 26,929,000 26,174,000 27,022,000 26,905,000 26,955,000 
      research and development tax credit
    		         -301,000 -292,000         
      distributions paid to non-controlling interest holders
    		          -5,409,000         
      change in fair value of interest rate swap
    		                   
      change in fair value of contingent earn-out liability
    		                   
      proceeds from repayments of loans to related companies
    		                   
      limited partners’ interest
    		                   
      proceeds from term loan
    		                   
      dividends paid
    		                   
      withholding tax paid on behalf of employees on stock based awards
    		                   
      changes in fair value of investments in equity securities
    		                   
      net increase in cash and cash equivalents
    		            37,244,000      118,230,000 
      cash and cash equivalents, beginning of the period
    		            0      128,029,000 
      issuance of loans
    		                   
      proceeds from issuance of shares
    		                   
      changes in fair value of contingent consideration
    		                 484,000 71,954,000 
      purchase of class a common stock in the initial public offering
    		                  -1,018,365,000 
      change in fair value of contingent consideration
    		                   
      other liabilities
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.